Trials / Sponsors / Lexeo Therapeutics
Lexeo Therapeutics
Industry · 7 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Clinical Course Of Disease In Participants With FA-CM Friedreich Ataxia, Cardiomyopathy | — | 2025-09-30 |
| Enrolling By Invitation | Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC | — | 2025-08-29 |
| Active Not Recruiting | Gene Therapy for ACM Due to a PKP2 Pathogenic Variant Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC | Phase 1 / Phase 2 | 2024-02-29 |
| Recruiting | A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-AC Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC | — | 2024-01-23 |
| Active Not Recruiting | Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease Alzheimer Disease | Phase 1 | 2023-05-08 |
| Active Not Recruiting | Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia Friedreich Ataxia, Cardiomyopathy, Secondary | Phase 1 / Phase 2 | 2022-08-24 |
| Completed | Gene Therapy for APOE4 Homozygote of Alzheimer's Disease Alzheimer Disease, Early Onset Alzheimer Disease | Phase 1 / Phase 2 | 2019-11-06 |